- Shares of Neuralstem (CUR +9.6%) pop this morning in response to its report of positive results of NSI-566 in ischemic-stroke rats. Those receiving 10K - 20K cells/ul revealed statistically significant better results compared to those receiving 5K cells/ul.
- NSI-566 is currently in a phase 2 trial for ALS.
Neuralstem reports positive study results
Recommended For You
About PALI Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
PALI | - | - |
Palisade Bio, Inc. |